Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FBXO32 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
HLA-DRB4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors
HERC2P9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ANK3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HABP4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PLXND1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM19A5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APBB2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100507472 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TECPR2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
C11orf31 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB46 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TRIM2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHPT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NR2F2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM165 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DIP2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FSD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CCNG2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LCP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on